Field

Field. Primary Field and Secondary Field collectively. Any commercial sale of research reagents covered by the Patent Rights is specifically excluded from the Field. The foregoing shall not be interpreted to prevent Company, its Affiliates or corporate partners from performing research related to discovery or development of Licensed Products for itself or any Affiliate or Sublicensee. (a) Primary Field means therapeutic, prophylactic, or diagnostic health care applications for amyotrophic lateral... sclerosis (ALS), diabetes, and obesity, in humans. (b) Secondary Field means therapeutic, prophylactic, or diagnostic health care applications in humans that are not included in the Primary Field. View More

Field. The prevention or treatment of any and all dermatological diseases and disorders in humans (i.e., diseases or disorders of the skin or nails including onychomycosis) but excluding diseases and disorders of the hair and any and all Rare Diseases, but shall exclude all Excluded Indications. For clarity, the Field excludes the Excluded Field

Field. The therapeutic classes of pharmaceutical or biotechnology products in which Zogenix or its licensees market products containing the Device as listed in Schedule 9.

Field. The prevention or treatment of Tourette's Syndrome.

Field. Means the Implantable Cardiac Field and the Neuro Field, collectively.

Field. Treatment of cardiac arrhythmia by catheter mediated ablation under simultaneous MR imaging and catheter mediated cardiac electrophysiological mapping under simultaneous MR imaging.

Field. Shall mean [***].

Field. The discovery, validation, development, application, production or sale of Licensed Products for the prevention, diagnosis and treatment of all human indications, diseases and conditions.

Field. Shall mean the discovery, validation, development, application, production or sale of Licensed Products: (i) for the prevention, diagnosis and treatment of Conformational Diseases (ii) that are Chaperones to improve the production and/or manufacturing of therapeutic proteins for the treatment of Conformational Diseases that are manufactured and sold by third parties, (iii) that are Chaperones discovered and developed by AMICUS to improve the production and/or manufacturing of therapeutic... proteins for the treatment of diseases other than Conformational Diseases that are manufactured and sold by third parties, or (iv) that are Chaperones discovered and developed by Amicus for co-administration with therapeutic proteins for the treatment of disease other than Conformational Diseases that are manufactured and sold by third parties. View More

Field. The term 'Field' shall mean feline immunodeficiency virus therapeutic research and development.